UnitedHealth Group Incorporated (UNH)
NYSE · Healthcare · Healthcare Plans
$378.58+1.80%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $340B
- P/E (trailing)
- 24.4
- Forward P/E
- 16.7
- Dividend yield
- 2.5%
- 52-week range
- $255.97 – $461.62
- 52-week change
- +2.27%
- EPS (trailing)
- $15.55
- Analyst rating
- 1.6 Buy
- Next earnings
- Oct 13, 2026
Fiscal year to Dec 2025
- Revenue
- $448B (+11.81%)
- Net income
- $12.1B
- Operating margin
- 4.2%
- Diluted EPS
- $13.23
- Free cash flow
- $16.1B
From the company’s annual report on SEC EDGAR.
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management.
Headquarters: Eden Prairie, United States · 390,000 employees · unitedhealthgroup.com